Athira Pharma Inc reports results for the quarter ended in December - Earnings Summary

LeonaBio

24/03/2022 21:48

* Athira Pharma Inc  ATHA.OQ  reported a quarterly adjusted
loss
of 45 cents​​ per share for the quarter ended in December. The
mean expectation of four analysts for the quarter was for a loss
of 54 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Athira Pharma Inc's reported EPS for the quarter was a
loss
of 45 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Athira Pharma Inc shares had fallen by 13.7% this quarter.
    * The company reported a quarterly loss of $16.73 million.
    * Wall Street's median 12-month price target for Athira
Pharma Inc
is $34.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 24 at 09:48 p.m.  ​All
figures in US dollars unless otherwise stated